Visby Medical Stock
HealthTechLooking to sell Visby Medical stock or options?
Visby Medical is a developer of diagnostic testing devices based on polymerase chain reaction (PCR) specifically designed for the detection of infectious diseases. The company excels in creating single-use handheld self-testing kits that yield instrument-free results. Visby Medical's range of medical services encompasses sexual health tests, respiratory health tests, and tests for other infectious diseases like COVID-19, chlamydia, gonorrhea, and trichomonas. This makes infectious disease testing as straightforward and accessible as possible for patients.
Nissim Capital, Highbury Group, Hutchison Port Group, Amplify Partners, Rheinest, Lightrock, CARB-X, Ling Wong, Ping An Voyager Partners, J-Ventures, Healthcare of Ontario Pension Plan, Blue Water Life Science Advisors, Cedars-Sinai, John Doerr, E Squared Capital Management, 1809 Capital, Omron Ventures, ND Capital, Dynamic Loop Capital, Artiman Ventures, Terrapin Partners, Seraph, Pitango Venture Capital, Justin Mateen, Biomedical Advanced Research and Development Authority.